Terms: = Kidney tumors AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Prognosis
8 results:
1. Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell carcinoma.
Meng L; Collier KA; Wang P; Li Z; Monk P; Mortazavi A; Hu Z; Spakowicz D; Zheng L; Yang Y
Cells; 2023 Dec; 13(1):. PubMed ID: 38201238
[TBL] [Abstract] [Full Text] [Related]
2. Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma.
Jang A; Lichterman JN; Zhong JY; Shoag JE; Garcia JA; Zhang T; Barata PC
Hum Vaccin Immunother; 2023 Dec; 19(3):2276629. PubMed ID: 37947202
[TBL] [Abstract] [Full Text] [Related]
3. Acute kidney Injury in Cancer Immunotherapy Recipients.
Joseph A; Lafarge A; Azoulay E; Zafrani L
Cells; 2022 Dec; 11(24):. PubMed ID: 36552755
[TBL] [Abstract] [Full Text] [Related]
4. Is CRP/Albumin Ratio (car) a New Parameter to be Added to Risk Stratification Systems in Metastatic Renal Cell carcinoma Patients?
Uzun M; Yildirim EC; Ekinci F; Semiz HS
J Coll Physicians Surg Pak; 2022 Nov; 32(11):1425-1429. PubMed ID: 36377009
[TBL] [Abstract] [Full Text] [Related]
5. Single-cell RNA-Seq reveals the potential risk of anti-mesothelin car T Cell therapy toxicity to different organs in humans.
Wen L; Huang Y; Peng L; Zhao K; Sun Y; Lin Z; Chen Y; Li Z; Qian Q; Tong F; Zhang R; Dong X
Front Immunol; 2022; 13():807915. PubMed ID: 36059490
[TBL] [Abstract] [Full Text] [Related]
6. Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.
Li W; Wang X; Zhang X; Gong P; Ding D; Wang N; Wang Z
Lipids Health Dis; 2021 Nov; 20(1):160. PubMed ID: 34774030
[TBL] [Abstract] [Full Text] [Related]
7. C-reactive protein to albumin ratio predicts the outcome in renal cell carcinoma: A meta-analysis.
Zhou W; Zhang GL
PLoS One; 2019; 14(10):e0224266. PubMed ID: 31644587
[TBL] [Abstract] [Full Text] [Related]
8. The need for immune biomarkers for treatment prognosis and response in genitourinary malignancies.
Slovin SF
Biomark Med; 2017 Dec; 11(12):1149-1159. PubMed ID: 29186979
[TBL] [Abstract] [Full Text] [Related]
